Implantable Maestro System

Implantable Maestro System is the primary FDA-endorsed corpulence gadget since 2007, is affirmed to treat patients matured 18 and more established who have not possessed the capacity to get more fit with healthy plan, and who have a body mass index of 35 to 45 with no less than one other obesity related condition, for example, sort 2 diabetes. BMI, which measures muscle to fat quotients in light of an individual's weight and stature, is utilized to characterize the overweight classifications. As per the Centre for Disease Control and Prevention, more than 33% of all U.S. grown-ups are obese, and individuals with overweight are at expanded danger of coronary illness, stroke, sort 2 diabetes and certain sorts of disease

    Related Conference of Implantable Maestro System

    October 27-28, 2026

    3rd Global Summit on Geriatrics & Aging

    Rome, Italy
    December 03-04, 2026

    9th Annual Summit on Surgery and Transplantation

    Madrid, Spain
    January 28-29, 2027

    6th World Congress on Cardiac Surgery and Medical Devices

    Vancouver, Canada
    February 18-19, 2027

    10th World Congress on Surgeons

    Singapore City, Singapore
    March 15-16, 2027

    7th World Congress on Surgery

    London, UK
    March 22-23, 2027

    13th International Conference on Surgeons

    Singapore City, Singapore

    Implantable Maestro System Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in